ClinicalTrials.gg
Sign In

Rhinitis, Allergic, Perennial clinical trials

The registry lists 178 studies for Rhinitis, Allergic, Perennial across more than 10 countries. 9 are recruiting or about to start. 143 of them are mainly about Rhinitis, Allergic, Perennial (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-27. Counting its narrower condition Dust Mite Allergy too: 219 studies, 14 open.

Get an email when these change. Save the Rhinitis, Allergic, Perennial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
155
Status unknown
8
Not yet recruiting
6
Terminated
3
Recruiting
3
Withdrawn
2

Phase

Phase 3
82
Phase 4
34
Phase 2
19
Phase 1
15

Where

United States
60
Korea, Republic of
16
Canada
9
China
8
Japan
7
Germany
6

Who runs them

GlaxoSmithKline (28) · Organon and Co (19) · AstraZeneca (9) · Sumitomo Pharma America, Inc. (8) · Sanofi (7) · ALK-Abelló A/S (5) · Boehringer Ingelheim (5) · National Institute of Allergy and Infectious Diseases (NIAID) (5)

What is being tested here

Drugs under test in Rhinitis, Allergic, Perennial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fluticasone11221
MM09122
CM512101
Ozureprubart101
Fluticasone furoate01115
Mometasone Furoate0710
Ciclesonide089
Montelukast046
Azelastine046
Levocetirizine016

Drug classes tested here Corticosteroids 1 open · Antihistamines 32

Coming up

3phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 3 Rhinitis, Allergic, Perennial studies recruiting now, 0 (0%) set no upper age limit and 3 (100%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
AgeWomenMen
100 (0%)0 (0%)
182 (67%)2 (67%)
303 (100%)3 (100%)
403 (100%)3 (100%)
503 (100%)3 (100%)
651 (33%)1 (33%)
750 (0%)0 (0%)
850 (0%)0 (0%)

Across all 178 studies, recruiting or not: 56% stop at 75 or younger and 52% at 65; 62% take children; 0% are for women only and 2% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rhinitis, Allergic, Perennial studies take

Of 17 phase 3 interventional studies under Rhinitis, Allergic, Perennial, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 38 mo2–15 · 17 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 178. Browse all 178 → or search them.